Conditions: Atherosclerotic Cardiovascular Disease (ASCVD)
Interventions: Drug: Lipid-lowering therapy targeting LDL-C <1.0 mmol/L; Drug: Lipid-lowering therapy targeting LDL-C 1.0-1.39 mmol/L
Sponsors: Beijing Anzhen Hospital
Not yet recruiting Conditions: Atherosclerotic Cardiovascular Disease (ASCVD)
Interventions: Drug: Lipid-lowering therapy targeting LDL-C <1.0 mmol/L; Drug: Lipid-lowering therapy targeting LDL-C 1.0-1.39 mmol/L
Sponsors: Beijing Anzhen Hospital
Not yet recruiting
